IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

TARANTINO, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 884
AS - Asia 748
NA - Nord America 549
SA - Sud America 61
AF - Africa 13
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.262
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 528
DE - Germania 475
SG - Singapore 233
CN - Cina 214
IT - Italia 134
HK - Hong Kong 116
SE - Svezia 63
RU - Federazione Russa 54
BR - Brasile 53
BD - Bangladesh 48
VN - Vietnam 47
FR - Francia 37
IN - India 31
GB - Regno Unito 29
FI - Finlandia 25
NL - Olanda 21
CA - Canada 13
KR - Corea 12
IE - Irlanda 9
CI - Costa d'Avorio 8
TR - Turchia 8
JP - Giappone 7
ID - Indonesia 6
AT - Austria 5
PH - Filippine 5
AU - Australia 4
BE - Belgio 4
ES - Italia 4
IR - Iran 4
PL - Polonia 4
TW - Taiwan 4
AR - Argentina 3
PT - Portogallo 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
DK - Danimarca 2
EC - Ecuador 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
LT - Lituania 2
MX - Messico 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
UA - Ucraina 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KZ - Kazakistan 1
MY - Malesia 1
NA - Namibia 1
SC - Seychelles 1
SV - El Salvador 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 2.262
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 448
Ashburn 121
Singapore 120
Hong Kong 98
San Jose 46
Hefei 42
Dallas 36
Milan 29
Beijing 24
Santa Clara 24
Los Angeles 23
Chandler 22
Helsinki 21
New York 21
Boardman 20
Hanoi 15
Council Bluffs 14
Ho Chi Minh City 14
Bengaluru 13
Moscow 13
Southend 13
Buffalo 10
Naples 10
Seoul 10
Dublin 9
Lauterbourg 9
Munich 9
Abidjan 8
Shanghai 8
Guangzhou 7
Oklahoma City 7
Rome 7
São Paulo 7
Atlanta 6
Chicago 6
Fuzhou 6
Istanbul 6
Shenzhen 6
Anacapri 5
Boston 5
Fisciano 5
Houston 5
Hyderabad 5
Tokyo 5
Wilmington 5
Bologna 4
Brussels 4
Düsseldorf 4
Jakarta 4
Paris 4
Princeton 4
Seattle 4
Seregno 4
Bari 3
Cangzhou 3
Dearborn 3
Dhaka 3
Gainesville 3
Grafing 3
Hangzhou 3
Lappeenranta 3
Melbourne 3
Montreal 3
Mumbai 3
Palermo 3
San Antonio 3
Taipei 3
The Dalles 3
Thái Bình 3
Toronto 3
Turin 3
Uxbridge 3
Vienna 3
Wuhan 3
Auckland 2
Baicheng 2
Barrie 2
Binghamton 2
Bonate Sotto 2
Brasília 2
Cairo 2
Cary 2
Changsha 2
Charlotte 2
Da Nang 2
Esztergom 2
Fairfield 2
Groningen 2
Haiphong 2
Hamburg 2
Jinan 2
Karachi 2
Lisbon 2
Madrid 2
Manchester 2
Pordenone 2
Pudong 2
Redwood City 2
Rio de Janeiro 2
Rostov-on-Don 2
Totale 1.490
Salva come PNG Salva come JPEG
Nome #
Management of patients with HER2-positive metastatic breast cancer after trastuzumab deruxtecan failure 325
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents 251
Bystander effect of antibody-drug conjugates: fact or fiction? 204
Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life 196
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment 193
HER2-Low Breast Cancer: Pathological and Clinical Landscape 181
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives 167
HER2-Low Breast Cancer: a New Subtype? 165
Characterization of low HER2 expressions in de-novo metastatic breast cancer 159
Baseline tumor size as prognostic index in patients with cancer receiving experimental targeted agents 146
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience 139
ANTIBODY-DRUG CONJUGATES FOR THE TREATMENT OF BREAST CANCER. 106
Clinicopathological features and genomics of ER-positive/HER2-negative breast cancer relapsing on adjuvant abemaciclib 52
A Comprehensive Review of the Growing Landscape of Endocrine and Biologic Treatments for Hormone Receptor-positive Breast Cancer 30
Resistance to Antibody-Drug Conjugates Targeting HER2 in Breast Cancer: Molecular Landscape and Future Challenges 6
Response to letter entitled: Re: Evolution of low HER2 expression between early and advanced-stage breast cancer 6
Biology and Treatment of HER2-Low Breast Cancer 4
Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast Cancer 3
Trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer treatment 1
Targeting HER3 for cancer treatment: a new horizon for an old target 1
Opportunities and challenges of implementing Pharmacogenomics in cancer drug development 1
Targeting HER2 in breast cancer: new drugs and paradigms on the horizon 1
The HER2-low revolution in breast oncology: steps forward and emerging challenges 1
Totale 2.338
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.206
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/202240 3 3 0 6 3 2 1 6 6 4 1 5
2022/202352 7 5 6 8 3 12 0 4 5 0 2 0
2023/2024487 12 17 14 23 39 30 77 58 26 58 63 70
2024/2025651 58 60 52 64 53 22 39 39 44 61 54 105
2025/20261.047 117 93 122 95 62 29 135 59 89 70 100 76
Totale 2.338